Through the unique ObjectiveGI platform, we’re offering pharmaceutical and biotech sponsors strong partnerships with research centers of excellence supported by our embedded study teams dedicated to driving results.
Research partnerships that drive results.
At ObjectiveGI, we have patient-centric technology and proprietary screening protocols that deliver superior patient enrollment metrics and reduce screen failures. We’ll work with you to design and deploy NASH research across the country with the aim of bringing clinical care solutions to market as efficiently as possible. With our access to EHRs, we are able to prescreen patients for studies, enabling us to meet trial enrollment needs.
Improving patient outcomes.
NASH clinical research isn’t possible without the patients who need our help. People with lives and families and hopes for better outlooks made possible through emerging science. These patients have a particularly difficult journey ahead of them. We keep all this in mind throughout every interaction with our patients. They are the reason for our work, and we couldn’t get to new therapies without them. So working closely with them and their doctors – along with constantly reminding our patients that they’re contributing to important research that one day will result in new therapies – is an ever-present part of our approach. This is how we’re transforming care for patients.
If you’re ready to conduct your research with centers of excellence that deliver consistent results, we’re ready to partner with you.